(Q39226104)

10 September 2017

title

Multidrug- and extensively drug-resistant TB in persons living with HIV. (English)

1 reference

Giovanni Battista Migliori

10 September 2017

main subject

multiple drug resistance

1 reference

based on heuristic

inferred from title

author

5

1 reference

10 September 2017

Rosella Centis

4

0 references

Alberto Matteelli

object named as

Alberto Matteelli

1

0 references

Giovanni Sotgiu

object named as

Giovanni Sotgiu

3

0 references

author name string

Morgan D'Arcy Richardson

2

1 reference

10 September 2017

publication date

1 June 2009

1 reference

Expert Review of Respiratory Medicine

10 September 2017

published in

1 reference

10 September 2017

volume

3

1 reference

10 September 2017

issue

3

1 reference

10 September 2017

page(s)

245-254

1 reference

Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa

10 September 2017

cites work

1 reference

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

21 January 2018

1 reference

Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: epidemiology and control.

21 January 2018

1 reference

Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis

21 January 2018

1 reference

Epidemiology and clinical management of XDR-TB: a systematic review by TBNET.

21 January 2018

1 reference

Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease

21 January 2018

1 reference

Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration

21 January 2018

1 reference

Primary transmission of multidrug-resistant and extensively drug-resistant tuberculosis among HIV-infected persons: what does the future hold in store?

21 January 2018

1 reference

HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers

21 January 2018

1 reference

HIV infection and multidrug-resistant tuberculosis: the perfect storm

21 January 2018

1 reference

Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa

21 January 2018

1 reference

Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy

21 January 2018

1 reference

Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials

21 January 2018

1 reference

Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update

21 January 2018

1 reference

Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis.

21 January 2018

1 reference

A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis

21 January 2018

1 reference

Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens

21 January 2018

1 reference

Genotype MTBDRplus: a further step toward rapid identification of drug-resistant Mycobacterium tuberculosis

21 January 2018

1 reference

Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa

21 January 2018

1 reference

GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis

21 January 2018

1 reference

Fluoroquinolones, tuberculosis, and resistance

21 January 2018

1 reference

Evaluation of a new line probe assay for rapid identification of gyrA mutations in Mycobacterium tuberculosis

21 January 2018

1 reference

Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis

21 January 2018

1 reference

Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?

21 January 2018

1 reference

Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases.

21 January 2018

1 reference

Comprehensive treatment of extensively drug-resistant tuberculosis.

21 January 2018

1 reference

Multidrug- and extensively drug-resistant tuberculosis, Germany

21 January 2018

1 reference

Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan

21 January 2018

1 reference

Extensively drug-resistant tuberculosis in california, 1993-2006.

21 January 2018

1 reference

Treatment outcomes and long-term survival in patients with extensively drug-resistant tuberculosis

21 January 2018

1 reference

Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome

21 January 2018

1 reference

Tuberculosis infection control in resource-limited settings in the era of expanding HIV care and treatment

21 January 2018

1 reference

Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis

21 January 2018

1 reference

Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)--a report of ten cases

21 January 2018

1 reference

Linezolid for the treatment of multidrug-resistant tuberculosis

21 January 2018

1 reference

Bactericidal activity of the nitroimidazopyran PA-824 in a murine model of tuberculosis

21 January 2018

1 reference

OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice

21 January 2018

1 reference

Current status of some antituberculosis drugs and the development of new antituberculous agents with special reference to their in vitro and in vivo antimicrobial activities

21 January 2018

1 reference

Diarylquinolines target subunit c of mycobacterial ATP synthase

21 January 2018

1 reference

Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines

21 January 2018

1 reference

Clinical and operational value of the extensively drug-resistant tuberculosis definition

21 January 2018

1 reference

Extensively Drug-Resistant Tuberculosis Is Worse than Multidrug-Resistant Tuberculosis: Different Methodology and Settings, Same Results

21 January 2018

1 reference

Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis

21 January 2018

1 reference

Multidrug-resistant tuberculosis at an HIV testing center in Haiti

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERS.09.15

1 reference

release_qkkb5t3skncv7mkzqgeqx6r2nm

10 September 2017

Fatcat ID

0 references

1 reference